MLTX vs. ^GSPC
Compare and contrast key facts about MoonLake Immunotherapeutics (MLTX) and S&P 500 (^GSPC).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MLTX or ^GSPC.
Performance
MLTX vs. ^GSPC - Performance Comparison
Returns By Period
In the year-to-date period, MLTX achieves a -14.12% return, which is significantly lower than ^GSPC's 24.72% return.
MLTX
-14.12%
8.04%
29.78%
14.46%
N/A
N/A
^GSPC
24.72%
1.67%
12.93%
30.55%
13.88%
11.16%
Key characteristics
| MLTX | ^GSPC | |
|---|---|---|
| Sharpe Ratio | 0.41 | 2.54 |
| Sortino Ratio | 0.93 | 3.40 |
| Omega Ratio | 1.11 | 1.47 |
| Calmar Ratio | 0.53 | 3.66 |
| Martin Ratio | 0.84 | 16.26 |
| Ulcer Index | 24.94% | 1.91% |
| Daily Std Dev | 50.87% | 12.23% |
| Max Drawdown | -64.60% | -56.78% |
| Current Drawdown | -18.79% | -0.88% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between MLTX and ^GSPC is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
MLTX vs. ^GSPC - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for MoonLake Immunotherapeutics (MLTX) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Drawdowns
MLTX vs. ^GSPC - Drawdown Comparison
The maximum MLTX drawdown since its inception was -64.60%, which is greater than ^GSPC's maximum drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for MLTX and ^GSPC. For additional features, visit the drawdowns tool.
Volatility
MLTX vs. ^GSPC - Volatility Comparison
MoonLake Immunotherapeutics (MLTX) has a higher volatility of 14.53% compared to S&P 500 (^GSPC) at 3.96%. This indicates that MLTX's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.